Imagion Biosystems has released its Quarterly Cashflow Report for the period ending 30 September 2019.
Read Appendix 4C.
The Stock Network Interview – Making the business case for MagSense® cancer imaging
Izaac Ronay from The Stock Network sat down with Imagion Biosystems’ Ward Detwiler to discuss the new written series, “10 Things to Know About MagSense®”, which
